BioSig in the News :: BioSig Technologies, Inc. (BSGM)

Westport Company May Hold Key To COVID Anti-Viral Drug

Near ‘Party Zero’ in Westport, firm tackles possible coronavirus cure

With heart surgery device selling, Westport innovator eyes wider relevance

Industry Assessment: A Roundtable of Medtech Executives

Team Up to Advance Bioelectronics

BioSig’s PURE EP System Captures Clear Cardiac Signals in First Clinical Cases

BioSig unlocking future of bioelectronic medicine through signal processing

Emergence of Advanced Electrocardiographic Technologies Show Major Promise for Electrophysiology (EP) Industry

BioSig uplists to small-cap Nasdaq exchange amid cardiac device push

View All Media Coverage News

Video Resources

Fox Business News: Nick Spring, CEO of ViralClear, Talks about the Company’s Progress on Claman Countdown

Nasdaq TradeTalks: Potential treatment for Covid-19

SumZero Headlines: Ken Londoner on Biotech Solutions in Signal Processing

The Future of Bioelectronic Medicine with Suraj Kapa, M.D.

Nasdaq Spotlight: Interview with Ken Londoner

Ken Londoner interviewed by Christine Corrado for Proactive Investors

Ken Londoner interviewed by Ray Hoffman for CEO Radio-WCBS

BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market

Greg Greenberg sits down with Kenneth Londoner, Executive Chairman of BioSig Technologies

View All Video Resources News